NICE medtech evaluation centres to work with manufacturers of close-call products
This article was originally published in Clinica
The next phase in the evolution of the UK National Institute for Health and Clinical Excellence’s medical technologies evaluation programme (MTEP) will introduce at least one important development in the process of evaluating devices and diagnostics.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.